Glycogen storage disease due to muscle phosphorylase kinase deficiency

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:715OMIM:300559E74.0
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Glycogen storage disease due to muscle phosphorylase kinase deficiency (also known as GSD type IXd or muscle-specific phosphorylase kinase deficiency) is a rare inherited metabolic disorder affecting skeletal muscle. Phosphorylase kinase is a key enzyme that activates glycogen phosphorylase, which is responsible for breaking down glycogen into glucose for energy use. When this enzyme is deficient specifically in muscle tissue, glycogen accumulates abnormally in skeletal muscle cells, impairing the muscle's ability to generate energy during exercise. Affected individuals typically present with exercise intolerance, muscle cramps, myalgia (muscle pain), and fatigue, particularly during vigorous physical activity. Some patients may experience episodes of myoglobinuria (dark-colored urine due to muscle breakdown) following strenuous exercise, which in severe cases can lead to acute kidney injury. Muscle weakness may be mild and progressive. The severity of symptoms can vary considerably among affected individuals. Onset is generally in childhood or adolescence, though milder cases may not be recognized until adulthood. Phosphorylase kinase is a complex enzyme composed of four subunits (alpha, beta, gamma, and delta), and mutations in different subunit genes can cause tissue-specific or generalized forms of phosphorylase kinase deficiency. The muscle-specific form (GSD IXd) is caused by mutations in the PHKA1 gene (encoding the muscle-specific alpha subunit), which is located on the X chromosome, making this form X-linked recessive. Management is primarily supportive and includes avoidance of intense anaerobic exercise, dietary modifications to ensure adequate energy supply, and careful monitoring of kidney function during episodes of rhabdomyolysis. A high-protein diet and moderate aerobic exercise conditioning may be beneficial. There is currently no specific curative treatment available.

Also known as:

Clinical phenotype terms— hover any for plain English:

CamptocormiaHP:0100595Progressive muscle weaknessHP:0003323Increased muscle glycogen contentHP:0009051Reduced muscle phosphorylase kinase activityHP:6000198MyoglobinuriaHP:0002913
Inheritance

X-linked recessive

Carried on the X chromosome; typically affects males more than females

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Glycogen storage disease due to muscle phosphorylase kinase deficiency.

View clinical trials →

No actively recruiting trials found for Glycogen storage disease due to muscle phosphorylase kinase deficiency at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Glycogen storage disease due to muscle phosphorylase kinase deficiency community →

No specialists are currently listed for Glycogen storage disease due to muscle phosphorylase kinase deficiency.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Glycogen storage disease due to muscle phosphorylase kinase deficiency.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Glycogen storage disease due to muscle phosphorylase kinase deficiencyForum →

No community posts yet. Be the first to share your experience with Glycogen storage disease due to muscle phosphorylase kinase deficiency.

Start the conversation →

Latest news about Glycogen storage disease due to muscle phosphorylase kinase deficiency

No recent news articles for Glycogen storage disease due to muscle phosphorylase kinase deficiency.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Glycogen storage disease due to muscle phosphorylase kinase deficiency

What is Glycogen storage disease due to muscle phosphorylase kinase deficiency?

Glycogen storage disease due to muscle phosphorylase kinase deficiency (also known as GSD type IXd or muscle-specific phosphorylase kinase deficiency) is a rare inherited metabolic disorder affecting skeletal muscle. Phosphorylase kinase is a key enzyme that activates glycogen phosphorylase, which is responsible for breaking down glycogen into glucose for energy use. When this enzyme is deficient specifically in muscle tissue, glycogen accumulates abnormally in skeletal muscle cells, impairing the muscle's ability to generate energy during exercise. Affected individuals typically present with

How is Glycogen storage disease due to muscle phosphorylase kinase deficiency inherited?

Glycogen storage disease due to muscle phosphorylase kinase deficiency follows a x-linked recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.